Department of Error

No authors listed

Published Erratum

No authors listed. Lancet. 2023.

. 2023 Jan 21;401(10372):194.

doi: 10.1016/S0140-6736(22)02581-8. Epub 2022 Dec 19.

No abstract available

Erratum for

An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study.
Guttman-Yassky E, Simpson EL, Reich K, Kabashima K, Igawa K, Suzuki T, Mano H, Matsui T, Esfandiari E, Furue M. Guttman-Yassky E, et al. Lancet. 2023 Jan 21;401(10372):204-214. doi: 10.1016/S0140-6736(22)02037-2. Epub 2022 Dec 9. Lancet. 2023. PMID: 36509097 Clinical Trial.